Cowealth Medical Holding Co (ROCO:4745) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4745 Cowealth Medical Holding Co Ltd ROCO:4745
52 GF Score
Price NT$10.80
GF Value NT$13.00
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cowealth Medical Holding Co FFO per Share?

FFO per Share only applies to REITs.

ROCO:4745
52GF Score
Cowealth Medical Holding Co Ltd ROCO:4745
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?

Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be undervalued. The current stock price of NT$10.80 is trading 16.9% below its estimated GF Value™ of NT$13.00. GuruFocus considers Cowealth Medical Holding Co to be Modestly Undervalued.

Key valuation signals for ROCO:4745:

  • FFO per Share:
  • GF Value™: NT$13.00 vs. price of NT$10.80 (16.9% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cowealth Medical Holding Co Business Description

Address North Sound Road, Suite 102, Cannon Place, P.O. Box 712, George Town, Grand Cayman, CYM, KY1-9006
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
52GF Score

Get the complete analysis for ROCO:4745

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$10.80
Price
NT$13.00
GF Value